Skip to the page

Data / Form D filings / Capsulomics, Inc.

Capsulomics, Inc.: Form D filings

Capsulomics, Inc., a biotechnology company in Halethorpe, MD, filed 2 Form D notices with the SEC between 2020 and 2025. The latest, on March 19, 2025, reports $2.4 million sold of a $3 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1450 S ROLLING ROAD, SUITE 3 013, Halethorpe, MD, 21227
Phone
(877) 844-4487
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Maryland
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1800623

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 19, 2025Amendment$3,000,000$2,392,270$607,73010Dec 17, 2019sec.gov
Jan 22, 2020New notice$50,000$50,0002Dec 17, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John NeiderhuberDirector
Daniel LunzExecutive Officer, Director
William StevensExecutive Officer
Stephen MeltzerDirector

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Mar 17, 2025 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Capsulomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.